API manufacturing

AbbVie Invests $195 Million in US API Production

AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the US.

Cambrex Expands Swedish Drugs Facility

Cambrex is spending $3.6 million to expand flexible drug substance manufacturing at its site in Karlskoga, Sweden. Engineering has already begun, and work is expected to be completed by November 2020.

Winning Strategies in the Pharmaceutical CDMO Industry

Science that Enables Solutions for Clean Air, Improved Health and Sustainable Use of Resources

Meeting Customers’ Changing Needs

Cambrex Announces Investment & Expansion

Easy Access for Customers

Good Manufacturing Practices

AMRI Promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing

Dr. Reddy's CPS Business Expands Manufacturing Operations in Mirfield, UK

Helsinn Advanced Synthesis Successfully Inspected by FDA

Innovation Expected from API Manufacturers

Johnson Matthey Q1 Underlying Profit Rises; Sees Strong Growth In H1

Carbogen Amcis Announces Plan to Restructure